BCG Vaccination
5
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
12 treatments under study, led by Bcg Vaccination With Micronjet600
Research Leaders
7 sponsors active, led by Yonsei University
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Trained Immunity in Fungal Infection and Its Mechanism
Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study
Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?
Clinical Study to Evaluate Safety and Immunogenicity of Bacillus Calmette-Guerin (BCG) Delivery Via Novel Micronjet600 Device Compared to Those Via Conventional Needle
Role of BCG as Booster Vaccination
Research Network
Common Treatments
- Bcg Vaccination With Micronjet6001
- Metformin Is Administered On The Day 851
- Bcg Vaccination1
- Bcg1
- Tdr1
Active Sponsors
- Yonsei University1
- Zhongnan Hospital1
- Eshmoun Clinical Research Center1
- Assiut University1
- Radboud University Medical Center1
Top Investigators
Radboud University Medical Center
Hopital Abderrahmane Mami
Related Conditions
- Covid191
- Tuberculosis1
- Covid 191